Inhibition of tissue factor signaling suppresses tumor growth
Author:
Affiliation:
1. Department of Immunology and
2. Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA;
3. University of California Davis, Sacramento; and
4. Sidney Kimmel Cancer Center, San Diego, CA
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/111/1/190/1219845/zh800108000190.pdf
Reference53 articles.
1. Tissue factor, thrombin, and cancer.;Rickles;Chest,2003
2. Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans.;Rak;Cancer Res,2006
3. Thrombin generation and the pathogenesis of cancer.;Ruf;Semin Thromb Hemost,2006
4. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.;Schulman;N Engl J Med,2000
5. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.;Mueller;Proc Natl Acad Sci U S A,1992
Cited by 284 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tissue factor pathway-related biomarkers in liver cancer: activated factor VII–antithrombin complex and tissue factor mRNA levels are associated with mortality;Research and Practice in Thrombosis and Haemostasis;2024-01
2. TF/PAR2 Signaling Axis Supports the Protumor Effect of Neutrophil Extracellular Traps (NETs) on Human Breast Cancer Cells;Cancers;2023-12-19
3. Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion;Journal of Thrombosis and Haemostasis;2023-12
4. Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-based immunotherapy by increasing lymphocyte infiltration in colorectal cancer;Journal for ImmunoTherapy of Cancer;2023-08
5. GPCRs and fibroblast heterogeneity in fibroblast‐associated diseases;The FASEB Journal;2023-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3